Skip to search.
 All Ordinaries Down 1.09%

Neostem, Inc. (NBS)

-NasdaqCM
2.77 Down 0.17(5.78%) 28 Mar 07:00
|After Hours : 2.77 0.00 (0.00%) 28 Mar 07:33
Add to Portfolio
Prev Close:2.94
Open:2.96
Bid:2.70 x 300
Ask:3.20 x 200
1y Target Est:18.67
Beta:-0.02
Next Earnings Date:N/A
Day's Range:2.67 - 2.98
52wk Range:2.67 - 7.39
Volume:845,086
Avg Vol (3m):323,469
Market Cap:106.53M
P/E (ttm):N/A
EPS (ttm):-1.68
Div & Yield:0.06 (1.00%)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
NBSDown 5.78%106.53M
BAXUp 0.78%37.19B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):6.30
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-15) :-1.50
Quarterly EPS Est (Mar-15) :-0.35
Mean Recommendation*:1.7
PEG Ratio (5 yr expected):-0.04

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

NeoStem, Inc., a clinical-stage biopharmaceutical company, develops cell based therapeutics in the United States. It is developing NBS20, a targeted cancer immunotherapy product that is in Phase III clinical trials for the treatment of metastatic ... View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback